Menu

西罗莫司片进医保了吗?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

(sirolimus) is covered by medical insurance? Many patients have asked this question recently. Sirolimus tablets are suitable for patients aged 13 or above who have received kidney transplants to prevent organ rejection. Recommended for use in combination with cyclosporine and corticosteroids. Sirolimus inhibits the activation and proliferation of T lymphocytes stimulated by antigens and cytokines (interleukins IL-2, IL-4 and IL-15). It also inhibits the production of antibodies. In cells, sirolimus binds to the immunophilin, FK-binding protein-12 (FKBP-12), to generate the FKBP-12 immunosuppressive complex. This complex binds to the mammalian sirolimus BA molecule (mTOR, a key regulatory kinase) and inhibits its activity, thereby inhibiting the progression from G1 to S phase in the cell cycle.

Medically insured drugs refer to drugs that are necessary to ensure the clinical treatment of employees and are included in the scope of basic medical insurance benefits. They are divided into Category A and Category B. Since sirolimus tablets (sirolimus) cannot be found in the "Basic Medical Insurance Drug Catalog", sirolimus tablets (sirolimus) are not yet medically insured drugs. Patients need to pay for them at their own expense. It is recommended to buy them at regular hospitals. Kidney transplantation is the transplantation of a kidney from a healthy person to a patient with kidney disease and loss of kidney function. It is an effective method to treat chronic renal failure. Sirolimus tablets (sirolimus) can inhibit the activation and proliferation of T lymphocytes stimulated by antigens and cytokines, and also inhibit the production of antibodies, which can prolong the survival of kidney transplant patients.

From the above information, we can know that sirolimus tablets (sirolimus) are already on the market, but have not yet been included in the ranks of medical insurance. If patients want to buy sirolimus at an affordable price and with ideal efficacy, please consult the medical companion travel service and we will provide you with services.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。